When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Treatment of lung cancer - Wikipedia

   en.wikipedia.org/wiki/Treatment_of_lung_cancer

   In 2021, the FDA approved amivantamab as the first treatment for patients with metastatic non-small cell lung cancer with epidermal growth factor receptor exon 20 insertion mutation. [50] [51] The first line treatment of advanced/metastatic NSCLC can incorporates immunotherapy either as a single modality or with chemotherapy. [16]

3. Gilead Sciences (GILD) Q4 2024 Earnings Call Transcript - AOL

   www.aol.com/gilead-sciences-gild-q4-2024...

   In lung cancer, Trodelvy continues to be evaluated in combination with pembro in first-line PD-L1 high metastatic nonsmall cell lung cancer in the phase 3 EVOKE-03 study.

4. Small-cell carcinoma - Wikipedia

   en.wikipedia.org/wiki/Small-cell_carcinoma

   Small-cell lung carcinoma (SCLC) has long been divided into two clinicopathological stages, termed limited stage (LS) and extensive stage (ES). [8] The stage is generally determined by the presence or absence of metastases, whether or not the tumor appears limited to the thorax, and whether or not the entire tumor burden within the chest can feasibly be encompassed within a single radiotherapy ...

5. Limited-stage small cell lung carcinoma - Wikipedia

   en.wikipedia.org/wiki/Limited-stage_small_cell...

   median overall survival time of approximately 12–16 months, with five-year survival rate of approximately 26% and the long-term survival rate of approximately 4 - 5%. Limited-stage small cell lung carcinoma (LS-SCLC) is a type of small cell lung cancer (SCLC) that is confined to an area which is small enough to be encompassed within a ...

6. Lung cancer - Wikipedia

   en.wikipedia.org/wiki/Lung_cancer

   Lung cancer most commonly metastasizes to the brain, bones, liver, and adrenal glands. [14] Lung cancer can often appear as a solitary pulmonary nodule on a chest radiograph or CT scan. In lung cancer screening studies as many as 30% of those screened have a lung nodule, the majority of which turn out to be benign. [15]

7. Non-small-cell lung cancer - Wikipedia

   en.wikipedia.org/wiki/Non-small-cell_lung_cancer

   The main treatment arms of phase 3 clinical trials providing immunotherapy in the first line for patients with non-small cell lung cancer. [59] Non-small cell lung cancer (NSCLC) cells expressing programmed death-ligand 1 (PD-L1) could interact with programmed death receptor 1 (PD-1) expressed on the surface of T cells, and result in decreased ...